Search results
New Brunswick mulls future of COVID-19 rapid tests, as virus kills 2, hospitalizes child under 4
CBC via Yahoo News· 4 hours agoNew Brunswick is mulling the future of its COVID-19 rapid point-of-care testing program, as the...
The images that show the other side of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo News· 12 minutes agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
COVID-19 Proteins Can Hang Around In The Blood For Up To 14 Months After Infection
IFLScience· 1 day agoThe idea that SARS-CoV-2, the virus behind COVID-19, may be able to persist in the body long after...
America’s Infectious-Disease Barometer Is Off
The Atlantic· 1 hour agoThe ongoing outbreak of H5N1 avian flu virus looks a lot like a public-health problem that the United States should be well prepared for. Although this...
Pfizer confirms COVID pill's results, potency versus omicron
AOL· 4 days agoPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron...
BioVie secures $13.1M funding from US Department of Defense for Long COVID treatment
Proactive Investors· 1 day agoLong COVID is characterized by prolonged symptoms following COVID-19 infection. The trial, expected...
Shortness of breath, fatigue characterises Long COVID
Cosmos· 4 days agoA study of Swedish Long COVID patients has revealed the symptoms most commonly associated with the...
Ohio COVID-19 cases fall for 10th straight week: Coronavirus update for Thursday, April 25
The Cleveland Plain Dealer· 5 days agoAt least 1,343,837 Ohioans have received the updated one-dose COVID-19 vaccine, an increase of 3,162...
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 6 days agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19 ...
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
WCMH Columbus· 6 days ago(Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the first patient has been enrolled in the Austere environments Consortium for Enhanced ...